# FDA Inspection 1122658 - UCARM Stapleton Clinic - February 26, 2020

Source: https://www.keypedia.com/records/fda_inspections/ucarm-stapleton-clinic/64f9032e-1353-4dbb-b4da-329d8ae6bb43
Source feed: FDA_Inspections

> FDA Inspection 1122658 for UCARM Stapleton Clinic on February 26, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122658
- Company Name: UCARM Stapleton Clinic
- Inspection Date: 2020-02-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122658 - 2020-02-26](https://www.keypedia.com/records/fda_inspections/ucarm-stapleton-clinic/80db5ecd-3818-4d14-b96d-9dc597390393)
- [FDA Inspection 998147 - 2017-01-10](https://www.keypedia.com/records/fda_inspections/ucarm-stapleton-clinic/1c1cd5e8-b0bd-463b-ade6-21f7076c67a5)
- [FDA Inspection 868586 - 2014-03-03](https://www.keypedia.com/records/fda_inspections/ucarm-stapleton-clinic/e0141a3c-3d4f-4ae5-94b0-16536c1642ec)

Company: https://www.keypedia.com/companies/ucarm-stapleton-clinic/cd6acb42-047a-4843-a652-7e262503ff70

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d